Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-10-28

Clinical Trial Update: A Study in Patients With Trichotillomania [Phase 2]

View source ↗

Summary

Phase 2 clinical trial in patients with trichotillomania has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Promentis Pharmaceuticals, Inc. | Conditions: Trichotillomania | Phase 2 | Status: COMPLETED